Shopping Cart
- Remove All
- Your shopping cart is currently empty
Terflavoxate is a novel, orally active, semisynthetic statin microtubule inhibitor commonly used in combination with capecitabine. Terflavoxate is used in cancer research.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $195 | In Stock | |
5 mg | $440 | In Stock | |
10 mg | $648 | In Stock | |
25 mg | $987 | In Stock | |
50 mg | $1,390 | In Stock | |
100 mg | $1,870 | In Stock | |
500 mg | $3,730 | In Stock |
Description | Terflavoxate is a novel, orally active, semisynthetic statin microtubule inhibitor commonly used in combination with capecitabine. Terflavoxate is used in cancer research. |
In vitro | Terflavoxate showed affinity for bladder (and brain) muscarinic receptors at micromolar level. Terflavoxate could inhibiting the two components of K(+)-induced contractions. Present results suggest that Ca(++)-antagonistic effects are mainly responsible for terflavoxate smooth muscle relaxant properties.[1] |
Molecular Weight | 419.51 |
Formula | C26H29NO4 |
Cas No. | 86433-40-1 |
Smiles | C(OC(CN1CCCCC1)(C)C)(=O)C2=C3C(C(=O)C(C)=C(O3)C4=CC=CC=C4)=CC=C2 |
Storage | Shipping with blue ice. | ||||||||||||||||||||
Solubility Information | DMSO: 4.19 mg/mL (10 mM), Sonication is recommended. | ||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.